Stay updated on PRT1419 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the PRT1419 in Hematologic Malignancies Clinical Trial page.

Latest updates to the PRT1419 in Hematologic Malignancies Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the website revision identifier changes from v3.7.1 to v3.7.2. The study record content remains unchanged.SummaryDifference0.8%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check43 days agoChange DetectedThe sponsor name is updated from Prelude Therapeutics to Prelude Therapeutics Incorporated, and the revision indicator updates to v3.7.0, replacing the prior sponsor entry and revision v3.6.6.SummaryDifference0.3%

- Check57 days agoChange DetectedThe page history now shows a new site revision, v3.6.6, replacing the previous v3.6.5. This is a system update to the page rather than a change to the study data or content.SummaryDifference0.1%

- Check78 days agoChange DetectedA new revision entry (v3.6.5) has been added to the record history, reflecting an updated release of the ClinicalTrials.gov page. The previous revision (v3.6.4) is removed from the visible history sequence.SummaryDifference0.1%

- Check93 days agoChange DetectedThe record history now shows the latest site revision as v3.6.4, replacing the previous v3.6.3, indicating an update to the Web interface.SummaryDifference0.1%

Stay in the know with updates to PRT1419 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PRT1419 in Hematologic Malignancies Clinical Trial page.